ecteinascidin 743 has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Allavena, P; Belgiovine, C; Colombo, FS; D'Incalci, M; Digifico, E; Frapolli, R; Liguori, M; Meroni, M | 1 |
| Colombo, T; D'Incalci, M; Donald, S; Frapolli, R; Gant, TW; Gescher, AJ; Greaves, P; Jimeno, J; Lopez-Lazaro, L; Meco, D; Riccardi, R; Verschoyle, RD; Zaffaroni, M; Zucchetti, M | 1 |
| Colombo, T; D'Incalci, M; Donald, S; Falcioni, C; Gescher, AJ; Greaves, P; Jimeno, J; Manson, MM; Steward, WP; Verschoyle, RD; Zaffaroni, M; Zucchetti, M | 1 |
3 other study(ies) available for ecteinascidin 743 and Experimental Neoplasms
| Article | Year |
|---|---|
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.
Topics: Adaptive Immunity; Animals; Antineoplastic Agents, Alkylating; Fibrosarcoma; Immune Checkpoint Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Programmed Cell Death 1 Receptor; Trabectedin; Tumor Escape; Tumor-Associated Macrophages | 2021 |
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP3A; Dexamethasone; Dioxoles; Down-Regulation; Drug Interactions; Female; Gene Expression; Isoquinolines; Liver; Liver Diseases; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oligonucleotide Array Sequence Analysis; Oxidoreductases, N-Demethylating; Rats; Rats, Inbred F344; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin | 2003 |
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Antioxidants; Chemoprevention; Diet; Dioxoles; Female; Indoles; Isoquinolines; Liver; Mammary Neoplasms, Animal; Neoplasms, Experimental; Rats; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin | 2004 |